Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 1, 2008, Pages 25-31

  Sakaguchi, Hisashi ^a   Marui, Akira ^a   Hirose, Keiichi ^a   Nomura, Takamasa ^a   Arai, Yoshio ^a   Bir, Shyamal Chandra ^a   Huang, Yuhong ^a   Esaki, Jiro ^a   Tabata, Yasuhiko ^b   Ikeda, Tadashi ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; POLITEF; POLYLACTIDE CO CAPROLACTONE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BACTERIAL CELL; BLOOD CULTURE; BLOOD SAMPLING; BLOOD VESSEL GRAFT; CELL COUNT; CLINICAL EFFECTIVENESS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG TISSUE LEVEL; GRAFT INFECTION; INFECTION PREVENTION; INOCULATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RETROPERITONEUM; SURVIVAL RATE; SUSTAINED DRUG RELEASE; SUTURING METHOD;

ABSORBABLE IMPLANTS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HEXANOIC ACIDS; LACTONES; MALE; METHICILLIN RESISTANCE; POLYESTERS; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 37549034598     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.06.027     Document Type: Article

References (21)

1. Huh J., Chen J.C., Furman G.M., Malki C., King B., Kafie F., et al. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. J Surg Res. 74 (1998) 54-58
2. Jones L., Braithwaite B.D., Davies B., Heather B.P., and Earnshaw J.J. Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg. 5 (1997) 486-489
3. Hernandez-Richter T., Schardey H.M., Wittmann F., Mayr S., Schmitt-Sody M., Blasenbreu S., et al. Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur J Endovasc Surg. 26 (2003) 550-557
4. Henke P.K., Bergamini T.M., Rose S.M., and Richardson J.D. Current options in prosthetic vascular graft infection. Am Surg. 64 (1998) 39-46
5. Murphy G.J., Pararajasingam R., Nasim A., Dennis M.J., and Sayers R.D. Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl. 83 (2001) 158-163
6. Nasim A., Thompson M.M., Naylor A.R., Bell P.R.F., and London N.J.M. The impact of MRSA on vascular surgery. Eur J Endovasc Surg. 22 (2001) 211-214
7. Chiesa R., Astore D., Frigerio S., Garriboil L., Piccolo G., Castellano R., et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg. 102 (2002) 238-247
8. Hirose K., Marui A., Arai Y., Nomura T., Inoue S., Kaneda K., et al. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J Vasc Surg. 44 (2006) 377-382
9. Zhu Y., Chian K.S., Chan-Park M.B., Mhaisalkar P.S., and Ratner B.D. Protein bonding on biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue engineering. Biomaterials 27 (2006) 68-78
10. Giavaresi G., Tschon M., Borsari V., Daly J.H., Liggat J.J., Fini M., et al. New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation. Biomed Pharmacother. 58 (2004) 411-417
11. Fujimoto K., Yamamura K., Osada T., Hayashi T., Nabeshima T., Matsushita M., et al. Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. J Biomed Mater Res. 36 (1997) 564-567
12. Giacometti A., Cirioni O., Ghiselli R., Goffi L., Mocchegiani F., Riva A., et al. Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. J Antimicrobial Chemother. 46 (2000) 751-756
13. Yasim A., Guel M., Ciralik H., and Ergun Y. Gelatin-sealed Dacron graft is not more susceptible to MRSA infection than PTFE graft. Eur J Endovasc Surg. 32 (2006) 425-430
14. Chilukuri M.D., and Shah J.C. Local delivery of vancomycin for prophylaxis of prosthetic device related infections. Pharm Res. 22 (2005) 563-572
15. Koshiko S., Sasajima T., Muraki S., Azuma N., Yamazaki K., Chiba K., et al. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg. 35 (2002) 779-785
16. Hayes P.D., Nasim A., London N.J., Sayers R.D., Barrie W.W., Bell P.R., et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg. 31 (2000) 837-838
17. Ricotta J.J., Faggioli G.L., Stella A., Curl G.R., Peer R., Upson J., et al. Total excision and extra-anatomical bypass for aortic graft infection. Am J Surg. 162 (1991) 145-149
18. Seeger J.M., Pretus H.A., Welborn M.B., Ozaki K.C., Flynn T.C., and Huber T.S. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 32 (2000) 451-461
19. Young R.M., Cherry K.J., Davis P., Gloviczki P., Bower T.C., Panneton J.M., et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg. 178 (1999) 136-140
20. Gomes M.N., and Spear S.L. Pedicled muscle flaps in the management of infected aortofemoral grafts. Cardiovasc Surg. 2 (1994) 70-77
21. Nakajima N., Masuda M., Ichinose M., and Ando M. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg. 67 (1999) 1994-1996